User contributions
- 09:25, 2 November 2017 (diff | hist) . . (-4) . . m Pharmacovigilance (→I. Passive surveillance)
- 09:22, 2 November 2017 (diff | hist) . . (-3) . . m Adverse drug reaction (→Probable/ Likely:)
- 09:14, 2 November 2017 (diff | hist) . . (-4) . . m Adverse drug reaction (→Certain:)
- 09:02, 2 November 2017 (diff | hist) . . (+1) . . m Adverse drug reaction (→Inaccessible /unclassifiable:)
- 09:01, 2 November 2017 (diff | hist) . . (+2) . . m Adverse drug reaction (→Unlikely:)
- 09:01, 2 November 2017 (diff | hist) . . (+3) . . m Adverse drug reaction (→Possible:)
- 09:00, 2 November 2017 (diff | hist) . . (+4) . . m Adverse drug reaction (→Probable/ Likely:)
- 08:58, 2 November 2017 (diff | hist) . . (+4) . . m Adverse drug reaction (→Certain:)
- 08:57, 2 November 2017 (diff | hist) . . (+4) . . m Adverse drug reaction (→Reporting ADRs)
- 08:53, 2 November 2017 (diff | hist) . . (0) . . m Adverse drug reaction (→Adverse Drug Reactions Etiology)
- 08:46, 2 November 2017 (diff | hist) . . (+1) . . m Adverse drug reaction (→Examples of therapeutic side effects)
- 08:44, 2 November 2017 (diff | hist) . . (+1) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 08:37, 2 November 2017 (diff | hist) . . (+3) . . m Pharmacovigilance (→What is a signal?)
- 08:28, 2 November 2017 (diff | hist) . . (-2) . . m Pharmacovigilance (→II. Stimulated reporting)
- 03:49, 17 October 2017 (diff | hist) . . (+3) . . m Adverse drug reaction (→Examples of therapeutic side effects)
- 05:28, 26 September 2017 (diff | hist) . . (+4) . . m Pharmacovigilance
- 05:22, 26 September 2017 (diff | hist) . . (0) . . m Pharmacovigilance (→What is a signal?)
- 10:00, 22 September 2017 (diff | hist) . . (-2) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 06:33, 22 September 2017 (diff | hist) . . (+1) . . m Adverse drug reaction (→Latest News Stories)
- 06:30, 22 September 2017 (diff | hist) . . (-2) . . m Adverse drug reaction (→History)
- 06:22, 22 September 2017 (diff | hist) . . (0) . . m Adverse drug reaction (→Other Reportable Events)
- 06:19, 22 September 2017 (diff | hist) . . (0) . . m Adverse drug reaction (→A Suspected Adverse Reaction)
- 05:54, 22 September 2017 (diff | hist) . . (+1) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 05:52, 22 September 2017 (diff | hist) . . (0) . . m Adverse drug reaction (→Adverse Drug Reaction (ADR))
- 05:40, 22 September 2017 (diff | hist) . . (+222) . . m Adverse drug reaction (/* Adverse Event or Adverse Experience (AE)https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/international-conference-harmonisation/efficacy/clinical-safety-data-management-d...)
- 05:28, 22 September 2017 (diff | hist) . . (+1) . . m Pharmacovigilance (→The National Pharmacovigilance Centres)
- 06:22, 21 September 2017 (diff | hist) . . (+2) . . m Adverse drug reaction (→A Suspected Adverse Reaction)
- 06:13, 21 September 2017 (diff | hist) . . (+5) . . m Pharmacovigilance (→V. Targeted clinical investigations)
- 05:57, 21 September 2017 (diff | hist) . . (-2) . . m Pharmacovigilance (→Importance of Pharmacovigilance in Clinical Trials)
- 10:12, 19 September 2017 (diff | hist) . . (0) . . m Pharmacovigilance (→Why pharmacovigilance is needed in every country)
- 09:46, 19 September 2017 (diff | hist) . . (+2) . . m Pharmacovigilance (→Pharmacovigilance activities)
- 09:41, 19 September 2017 (diff | hist) . . (+2) . . m Pharmacovigilance (→Pharmacovigilance activities)
- 09:30, 19 September 2017 (diff | hist) . . (-2) . . m Pharmacovigilance
- 09:27, 19 September 2017 (diff | hist) . . (-1) . . m Pharmacovigilance
- 05:28, 19 September 2017 (diff | hist) . . (+1) . . m Pharmacovigilance
- 03:01, 19 September 2017 (diff | hist) . . (+1) . . m Adverse drug reaction (→Examples of therapeutic side effects)
- 09:55, 18 September 2017 (diff | hist) . . (+130) . . Nm userpage of Naveen Kumar (Creating userpage) (current)
